-
Community acquired pneumonia "bundles" often include the use of the pneumococcal urinary antigen assay, but how useful is it for streamlining antibacterial use?
-
In this issue: Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
-
A highly successful team approach to preventing blood stream infections shows similar efficacy against ventilator associated pneumonia (VAP), which was sharply reduced in more than 100 participating intensive care units.
-
With low rates of influenza immunization among healthcare workers still more the national rule than the occasional exception, the nation's largest infection prevention group has toughened its mandatory policy and closed some opt-out loopholes.
-
Money talks when it comes to infection prevention, particularly if it's coming out of your purse or wallet. That appears to be the lesson thus far of an infection control policy taken to an unusual extreme.
-
Although we cannot move away from rates of healthcare associated infections (HAIs) especially in this age of HAI public reporting and transparency health care professionals might need reminding that people are represented in any HAI data calculated, statistically analyzed or distributed.
-
A recently reported dramatic national reduction in central line associated blood stream infections (CLABSIs) puts a harsh light on hospitals that have not adopted a "checklist" protocol and other proven measures to fight infections that are both expensive and deadly.
-
In compiling national surveillance data on central line associated blood stream infections (CLABSIs) the Centers for Disease Control and Prevention made an interesting finding: Reductions in CLABSIs caused by Staphylococcus aureus were more marked than reductions in infections caused by gram-negative rods, such as Candida and Enterococcus.
-
In this study, 783 HIV-infected Indian mother-infant pairs participated in a randomized clinical trial comparing NVP given for 6 weeks vs. single-dose NVP to prevent MTCT of HIV among breast-fed infants.
